Spineology, a St.Paul, MN-based medical device company, raised $25M in Equity funding.
The round was led by SV Health Investors, with participation from 1315 Capital and its existing investor, RC Capital.
The company intends to use the funds to expand operations and its R&D sector.
Led by CEO Brian Snider, Spineology specializes in ultra-minimally invasive spine surgery, enabling surgeons to treat patients with spinal pathologies by optimizing outcomes, while minimizing tissue disruption and enhancing patient recovery. The OptiMesh technology is delivered through the smallest insertion portal in the lumbar interbody market, and dynamically conforms to a patient’s unique endplate morphology, expanding to one of the largest implant footprints available. OptiMesh is backed with Investigational device exemption (IDE) level data and holds the only De Novo Grant for spinal fusion.
FinSMEs
06/08/2024